Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Karin Kato, Sho Kodama, Kazuhito Shiosakai & Takeshi Kimura. (2023) Relationship between the dose titration and adherence of mirogabalin in patients with peripheral neuropathic pain depending on renal function: a nationwide electronic medical record database study. Expert Opinion on Pharmacotherapy 24:2, pages 267-282.
Read now
Read now
Takahiro Ushida, Mizuka Yokoyama, Kazuhito Shiosakai, Kengo Saito, Shigehisa Ibe & Kaoru Okuizumi. (2022) A large-scale database study for the prescription status of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, in Japan. Expert Opinion on Pharmacotherapy 23:2, pages 273-283.
Read now
Read now
Jitsu Kato, Teruyoshi Inoue, Mizuka Yokoyama & Masanori Kuroha. (2021) A review of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, for the treatment of peripheral neuropathic pain. Expert Opinion on Pharmacotherapy 22:17, pages 2311-2322.
Read now
Read now
Articles from other publishers (7)
Hui Tang, Jing Lu, Yazhuo Duan & Dejun Li. (2023) The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids. Mediators of Inflammation 2023, pages 1-13.
Crossref
Crossref
Huilian Bu, Pengfei Jiao, Xiaochong Fan, Yan Gao, Lirong Zhang & Haiming Guo. (2022) The role of botulinum toxin type A related axon transport in neuropathic pain induced by chronic constriction injury. The Korean Journal of Pain 35:4, pages 391-402.
Crossref
Crossref
Yuting Chen, Qingqing Wu, Zhengsheng Jin, Yanlan Qin, Fancui Meng & Guilong Zhao. (2022) Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling. Current Medicinal Chemistry 29:30, pages 5097-5112.
Crossref
Crossref
Eric Y. Chen, Sascha S. Beutler, Alan D. Kaye, Amber N. Edinoff, Seyed-Hossein Khademi, Andrea E. Stoltz, Nicole R. Rueb, Elyse M. Cornett & Winston J. Suh. (2021) Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence. Anesthesiology and Pain Medicine 11:6.
Crossref
Crossref
Abhijit Nair, Subodh Kamtikar & Suresh Seelam. (2021) Safety, tolerability, and efficacy of a selective gabapentinoid mirogabalin in neuropathic pain—a topical review. Ain-Shams Journal of Anesthesiology 13:1.
Crossref
Crossref
Jitsu Kato, Masayuki Baba, Masanori Kuroha, Yoshihiro Kakehi, Emiko Murayama, Yosuke Wasaki & Shoichi Ohwada. (2021) Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies. Clinical Therapeutics 43:5, pages 822-835.e16.
Crossref
Crossref
Jae-Yeon Kim, Salahadin Abdi, Billy Huh & Kyung-Hoon Kim. (2021) Mirogabalin: could it be the next generation gabapentin or pregabalin?. The Korean Journal of Pain 34:1, pages 4-18.
Crossref
Crossref